Management Team

Christopher Anzalone, Ph.D.
President and CEO

Dr. Anzalone is the President and Chief Executive Officer of Arrowhead Research and a majority stockholder of Unidym. He has a wealth of experience in nanotechnology, biotechnology, company-building, and venture capital. Prior to joining Arrowhead, Dr. Anzalone founded and built The Benet Group, a private equity firm focused on creating and building new nanobiotechnology companies from university-generated science. Included in The Benet Group's portfolio are investments in two nanotechnology companies: Nanotope Inc., a tissue regeneration company, and Leonardo Biosystems Inc., a cancer drug delivery company. Prior to Benet, Dr. Anzalone was a partner at the Washington DC-based private equity firm Galway Partners, LLC where he was in charge of sourcing, structuring, and building new business ventures. He was also the founding CEO of NanoInk, Inc., a leading nanolithography company.
Dr. Anzalone holds a Ph.D. and M.A. in Biology from UCLA and a B.A. in Government from Lawrence University.